Clinical Trial Update: Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients [Phase 1]

View source ↗

Summary

A phase 1 clinical trial evaluated the effect of Leflunomide on T cell proliferation in people with HIV infection. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED